Cardiac disease diagnosis

MYO Test Kit

Time-Resolved Fluorescent Immunochromatographic Assay

【General Information】

1.Method: Time-resolved Fluorescent Immunochromatographic Method 

2.Bio-marker tested: myoblobin (MYO)   

3.Clinical Sample: whole blood,  serum or plasma 

4.Other Specifications: in vitro, quantitative test

【Clinical significance】

1. As myocardial infarction (AMI) early detection indicators, highly sensitive 

2. Peaked 1-3h after the onset 

3. Diagnose reinfarction or infarct extension 

4. Determine myocardial re-perfusion


1. Advanced: time-resolved fluorescence immunoassay quantitative chromatography 

2. Quantitative: quantitative detection of myocardial infarction marker myoblobin (MYO) 

3. Accurate: well correlated with imported chemiluminescence reagent (r> 0.975)  

4. High sensitivity: lower detection limit <1.0 ng/mL  

5. Simple: simple operation, suitable for bedside detection 

6. Widely applicable : outpatient laboratory, emergency laboratory, medical center, cardiology, ICU, and etc 


Mar. 2014

CFDA approvals for five immunoassay reagents adaptable to most chemical analyzers were obtained

Feb. 2014

CFDA approvals for time-resolved fluorescence immunochromatographic analyzer were obtained

Sep. 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment